http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016137275-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc5fdf0f2197acd126d78225df71a935 |
| filingDate | 2016-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15ecae32fcaefed7a65698481ee1687a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0460e58ce4dc29bb1e38148b2f76828 |
| publicationDate | 2016-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2016137275-A2 |
| titleOfInvention | Composition for enhancing immunosuppressive activity of myeloid-derived suppressor cells and method for enhancing immunosuppressive activity using same |
| abstract | The present invention relates to a composition for enhancing immunosuppressive activity of myeloid-derived suppressor cells (MDSCc), the composition containing immunoregulatory T cells (Treg cells) and/or transforming growth factor-β (TGF-β), to a method for enhancing immunosuppressive activity of myeloid-derived suppressor cells (MDSCs) using the same, and to an immunosuppressive composition containing MDSCs differentiated into subpopulations by the treatment with immunoregulatory T cells and/or TGF-β. The use of the composition of the present invention can obtain MDSCs with enhanced immunosuppressive activity, and the use of the MDSCs can effectively prevent or treat immune-related diseases. |
| priorityDate | 2015-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 351.